chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Coworker had his third pfizer vaccine dose; Coworker had his third pfizer vaccine dose; fatigued enough to miss work; This is a spontaneous report from a non-contactable Other HCP via sales representative. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as Dose 3 (booster), Single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as Dose 1, Single via an unspecified route of administration on an unspecified date as Dose 2, Single for COVID-19 immunization. It was stated that, event took place after use of product. On an unspecified date (after booster dose administration), the patient had experienced fatigued enough to miss work. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Pain and tenderness in armpit (axillary lynph node inflamation) a few days after vaccination lastin up to 6 days post vaccination. resolved.
pain and swelling at shoulder was given high up. did not notice supraclavicular lymph node until this past Sunday
vial from this lot number was punctured on 08/16/2021.  9 days since puncture
starting to feel aches in hands, wrists, fingers; starting to feel aches in hands, wrists, fingers; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (starting to feel aches in hands, wrists, fingers) and ARTHRALGIA (starting to feel aches in hands, wrists, fingers) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis.    On 29-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (starting to feel aches in hands, wrists, fingers) and ARTHRALGIA (starting to feel aches in hands, wrists, fingers). At the time of the report, PAIN IN EXTREMITY (starting to feel aches in hands, wrists, fingers) and ARTHRALGIA (starting to feel aches in hands, wrists, fingers) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medicines were not provided,   Action taken with mRNA-1273 in response to the event was unknown.   Reporter did not allow further contact
Tiredness; Headache; Shivering; Fever; Upset stomach; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced tiredness, headache, shivering, fever and upset stomach. On an unknown date, the outcome of the tiredness, headache, shivering, fever and upset stomach were unknown.   The reporter considered the tiredness, headache, shivering, fever and upset stomach to be possibly related to Shingrix.  Additional information was received as follows: Age at vaccination was not reported. The patient reported experiencing tiredness, headache, shivering, fever, and upset stomach after receiving their 1st dose of the Shingrix vaccine. He stated he thiought he got "all" of the side effects from the vaccine. The reporter did not consent to follow-up.
3/14/2021 Goosebumps, shivering, fever (101.8), headache, nausea, achy.  Took Tylenol and it helped for about 3 hours.    03/15/2021 Woke up with symptoms again around 2:30 am and took Tylenol.  Woke up around 8 am with slight headache and VERY tired.  Kept a nagging headache and "brain fog" all of the day  and tired.  Took Tylenol and it helped some.  I felt a bit foggy all day even with Tylenol.  3/16/2021 Still felt tired with a bit of a headache on and off. Took Tylenol and it helped.    I don't take meds often so I just took 500 mg Tylenol, 1 tablet. I am healthy with no underlying conditions and do not have reactions to the flu shot.  I expected the same  with this shot.
At 15 days post booster I started to develop a severe itchy reaction in my scalp, neck and legs.   It appears to have turned into dermatographia.  I have tried creams as well as lotions, however the only thing that is giving me results is Benadryl.  This is now January 28th and if Benadryl is not used, the itching sensation returns.  Benadryl is taken 2-3x per day.
This case meets criteria for vaccine breakthrough review. SxS include weakness, frequent falls, loss of appetite, weight loss,
Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022; No adverse reaction; Dose administered after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date), PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022) and NO ADVERSE EVENT (No adverse reaction) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003K21-2A and 077C21B) for COVID-19 prophylaxis.     The patient's past medical history included Hepatobiliary disorder prophylaxis. Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included ESTRADIOL, PANTOPRAZOLE, LOSARTAN and ETODOLAC for an unknown indication.   On 23-Nov-2021 at 8:23 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 26-May-2022 at 2:19 PM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 26-May-2022 at 2:19 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022) and NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date), PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after expiration date) and PRODUCT STORAGE ERROR (Vial was expired on 13-May-2022, stored in refrigerator on 21-Jan-2022 and administered on 26-May-2022).    Patient had not ever been diagnosed with/ tested positive for COVID-19.  The event did not cause the patient to seek medical care. It was unknown if there was any other potential causes. It was unknown if the patient experienced a similar event in the past. The vial did not undergo any temperature excursions  No treatment medications were provided.
Is abdominal Pain normal; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Is abdominal Pain normal) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (Is abdominal Pain normal). At the time of the report, ABDOMINAL PAIN (Is abdominal Pain normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow- up received, patient's demographics were added.
04/10/2021     VACCINE  DOSE #1     J&J 08/4/2021       VACCINE DOSE #2     PFIZER 08/25/2021      VACCINE DOSE #3    PFIZER
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 14-NOV-2011, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the her injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earning capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
swelling in legs; swelling migrated to abdomen; edema/bloated up to his feet; cannot walk; feet hurts a lot; cannot see ankles due to swelling//crotch area swelling; gained over 20 lbs. but all fluid; swelling of lymph nodes on legs; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING, ABDOMINAL DISTENSION, OEDEMA, GAIT INABILITY, and PAIN IN EXTREMITY in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PERIPHERAL SWELLING (swelling in legs), ABDOMINAL DISTENSION, OEDEMA, GAIT INABILITY, PAIN IN EXTREMITY, SWELLING, FLUID RETENTION, and LYMPHADENOPATHY. At the time of the report, PERIPHERAL SWELLING, ABDOMINAL DISTENSION, OEDEMA, GAIT INABILITY, PAIN IN EXTREMITY, SWELLING, FLUID RETENTION, and LYMPHADENOPATHY outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.  No lab data information was provided.
patient was administered 0.5ml dose of the Pfizer vaccine by accident, more than the recommended dose of the vaccine; arm soreness; This is a spontaneous report from a contactable nurse who reported similar events for 3 patients. This is the 1st of 3 reports.  A 52-year-old patient of unspecified gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at 0.5 mL, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was administered 0.5ml dose of BNT162B2 by accident, more than the recommended dose of the vaccine, on an unspecified date, as they thought they were administering the Moderna vaccine. Upon follow up on 07Jan2021, it was reported that a nurse in the vaccination clinic inadvertently administered 0.5 ml of the Pfizer vaccine to 3 patients. The nurse reported that the patient was fine, only experienced a little arm soreness after receiving the vaccine. The outcome of the event was unknown.  Follow up (07Jan2021 and 08Jan2021): New information received from a contactable nurse includes: patient information (patient's age added) and course information.  Information about Lot/Batch number has been requested.  Follow-Up (11Feb2021): Follow-up attempts are completed. No further information is expected.  Follow-up (19Feb2020): New information from a contactable nurse includes new event (little arm soreness).  No follow-up attempts are possible. Information about lot/batch number cannot been obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021010560 same reporter, event and product, different patient;US-PFIZER INC-2021010559 same reporter, event and product, different patient
Severe explosive diarrhea lasting 4 hours, then just continued diarrhea for 3 hours then it subsided. No fever, no chills or other symptoms.
Site of injection was swollen. Recommended to take BENADRYL. Will follow up with patient in 2 days.
Stomach ache started 10 hours after injection. From there, violent vomiting, chills, feverish, headache, achey muscles, skin hurts when touched
This spontaneous report was received from a pharmacist referring to a female patient of unknown age. No pertinent medical history and concurrent conditions reported. On an unknown date in 2005 (reported as 9 years ago) the patient was vaccinated with first dose of GARDASIL, intramuscular (dose not reported). No other concomitant therapies reported. On 23-JUL-2014 the patient visited the pharmacy to receive the second dose of GARDASIL. No adverse effects reported. The outcome of the events was unknown. No PQC reported. Additional information is not expected.
Case number PHEH2012US013458 is an initial spontaneous report received from a nurse on 26 Jun 2012. This report refers to a male patient whose age was not reported. His medical history, past drugs, current conditions and concomitant medications were not specified. His vaccination history included administration of unspecified vaccine in 2007. He was vaccinated with MENACTRA (other manufacturer, batch number: not reported) on an unknown date in Mar 2012. It was reported that without noticing that he had been vaccinated with MENACTRA he was administered 0.5 ml intramuscular dose of MENVEO (batch number: M11073, expiry date: Dec 2013) on 26 Jun 2012. No adverse event was reported.
After 12 minutes, patient started to have periodic unresponsiveness. She claimed to have a bad headache and reported no problems with breathing.
Numbness in feet that spread to legs, trouble breathing?. Was given inhaler?. Neurologist said it was a mild case of guillain-barré
This spontaneous case reported by a consumer, describes the occurrence of product dose omission issue (considering the second shot/has it been too long to get it/first shot March 11) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 11, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, the patient experienced product dose omission issue (considering the second shot/has it been too long to get it/first shot March 11). At the time of the report, product dose omission issue (considering the second shot/has it been too long to get it/first shot March 11): resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
9/12/2021 Fever, Shortness of breathe, Dry cough, Lack of energy. 9/21/21 The patient went to a lab for a COVID test and it was negative.  9/22/21 the patient went to a general Doctor and was told he had inflammation of the heart.  Lab tests and an x-ray was ordered and intravenous antibiotics were administered for 3 days.  9/26/2021 the fever returned.  The Doctor prescribed Nebilet 5 mg and the patient started taking 1/2 tablet a day on 10/1/2021.On 10/11/2021 made an appointment with a cardiologist.  Because of pain in the heart went to the emergency room at the hospital on 10/12/2021. Dr. was the attending cardiologist and ordered an electrocardiogram which showed blockage in the left part of the
Pt recvd vax & devel erythema @ the inject site; pt has no induration & is afebrile;
woke up   got a severe headache  /feel like her headache, is  hurting, and stuffy,; had to stop working; 5 hours later started to feel extremely fatigue; during the night  ended up shaken , not cold but like shivering like when someone is cold, during the night  ended up shaken, not cold but like shivering like when someone is cold. This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (had to stop working), TREMOR (during the night  ended up shaken , not cold but like shivering like when someone is cold,), FATIGUE (5 hours later started to feel extremely fatigue), CHILLS (during the night  ended up shaken, not cold but like shivering like when someone is cold,) and HEADACHE (woke up got a severe headache  /feel like her headache, is  hurting, and stuffy,) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002M21a) for COVID-19 vaccination.     Patient has never tested positive for COVID-19.  Previously administered products included for Product used for unknown indication: Pfizer Biontech Covid-19 vaccine. Past adverse reactions to the above products included No adverse event with Pfizer Biontech Covid-19 vaccine.    On 25-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2022, the patient experienced TREMOR (during the night  ended up shaken , not cold but like shivering like when someone is cold,) and CHILLS (during the night  ended up shaken , not cold but like shivering like when someone is cold,). On 25-Apr-2022, the patient experienced IMPAIRED WORK ABILITY (had to stop working) and FATIGUE (5 hours later started to feel extremely fatigue). On 26-Apr-2022, the patient experienced HEADACHE (woke up   got a severe headache  /feel like her headache, is  hurting, and stuffy,). The patient was treated with NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. At the time of the report, IMPAIRED WORK ABILITY (had to stop working), TREMOR (during the night  ended up shaken , not cold but like shivering like when someone is cold,), FATIGUE (5 hours later started to feel extremely fatigue), CHILLS (during the night  ended up shaken , not cold but like shivering like when someone is cold,) and HEADACHE (woke up   got a severe headache  /feel like her headache, is  hurting, and stuffy,) outcome was unknown.            No concomitant medication was provided.  It was reported that 5 hours later started to felt extremely fatigue, had to stop working, and then during the night ended up shaken, not cold but like shivering when someone was cold, and continue all night. On 26-Apr-2022 got a severe headache, had to change their plans because did not know if there were going to have another event. The headache was hurting, and stuffy, even with taken medication.
Was fine til 7 pm the next day, had hallunicians, lost my speech dizzy and I had every emotion a person could have in 2 hrs, heart felt it was coming from my chest, I lost my balance and my side effects are continuing still I am falling cause i get dizzy headaches are worse there almost every day now.  I need information on how do I control this. ended up in the hospital for 8 hrs. most I don't remember as I was exhausted.
Severe Headache, Triggered Trigeminal Neuralgia, Rash, Fever, Large swelling at vaccine site, Short of Breath
Started having bad headache the day after shot. Also very bad fatigue. Now on 12/21/20 I?ve had a very severe migraine with visual aura.
I got Bell's Palsy 5 days after my second dose of Moderma Vaccine.
Chills, blood clot R DVT, Dizzy, balance difficulty, itchy  upper torso, sleeplessness
No adverse events. The patient came into our booster vaccine clinic with his father. The father requested a booster of Moderna, then requested his son to receive a Moderna booster. His son, however, was not 18 as of yet. This was unfortunately overlooked. Only the Pfizer booster is approved as of today for this age group.
Parent called clinic on 1/3/03 to report ongoing symptoms for child that began on 12/26/02 around 22:00. Child developed blotches-red on both thighs that spread to arms, feet, neck, chest and back. Child had an axillary temperature of 101.4F. Parent reports both eyes and lips were bright red. On the 27th, the rash on feet became "bumpy". Extremities were swollen, itchy and hard. Physician recommended Tylenol and Benadryl. On the 28th, child was taken to the ER when child's eyes were bloodshot and lips were red and bleeding. Child was given drops for eyes to prevent infection. Temperature decreased but redness and swelling in extremities continued throughout 1/3/03. T/C to mom on 1/6/3; child doing much better. Swelling and redness down but fingertips are peeling.
acute urticaria 9MAR95 DPH; 13MAR95 1/2cc Celistone IM; 16MAR95 1/2cc Celistone IM;
Vomiting; Chills; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced VOMITING (Vomiting), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue). On 18-Mar-2021, VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, FATIGUE (Fatigue) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
body soreness and aching; not feeling well; hurting on the joints; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body soreness and aching), MALAISE (not feeling well) and ARTHRALGIA (hurting on the joints) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (body soreness and aching), MALAISE (not feeling well) and ARTHRALGIA (hurting on the joints). At the time of the report, PAIN (body soreness and aching), MALAISE (not feeling well) and ARTHRALGIA (hurting on the joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided